Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-011512
Filing Date
2025-08-14
Accepted
2025-08-14 13:16:51
Documents
70
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgtx-20250630x10q.htm   iXBRL 10-Q 2368105
2 EX-31.1 mgtx-20250630xex31d1.htm EX-31.1 11270
3 EX-31.2 mgtx-20250630xex31d2.htm EX-31.2 13849
4 EX-32.1 mgtx-20250630xex32d1.htm EX-32.1 6661
5 EX-32.2 mgtx-20250630xex32d2.htm EX-32.2 6669
  Complete submission text file 0001558370-25-011512.txt   9221755

Data Files

Seq Description Document Type Size
6 EX-101.SCH mgtx-20250630.xsd EX-101.SCH 63179
7 EX-101.CAL mgtx-20250630_cal.xml EX-101.CAL 54291
8 EX-101.DEF mgtx-20250630_def.xml EX-101.DEF 241141
9 EX-101.LAB mgtx-20250630_lab.xml EX-101.LAB 471277
10 EX-101.PRE mgtx-20250630_pre.xml EX-101.PRE 396066
73 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20250630x10q_htm.xml XML 1699316
Mailing Address 655 THIRD AVENUE SUITE 1115 NEW YORK NY 10017
Business Address 655 THIRD AVENUE SUITE 1115 NEW YORK NY 10017 646-860-7985
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

EIN.: 981448305 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38520 | Film No.: 251216910
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)